Company / Shareholders' Equity
uniQure N.V. Shareholders' Equity History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$6.8M
FY2024
5-year range
-$6.8M / $595.8M
FY2020-FY2024
Trend
-103.3%
vs FY2023
Sector context
#194 of 213
Health Care
What the data says
uniQure N.V. reports negative total equity of -$7M in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$7M in FY2024.
Declined from $476M to -$7M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 213This company -$6.8M Sector average $2.5B
▼
-100.3% below sector average
Key checks
Key Insights
- uniQure N.V.'s shareholders' equity has declined for 3 consecutive years.
- In FY2024, shareholders' equity decreased 103.3% year-over-year.
- Ranks #194 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$6.8M | -103.3% |
| FY2023 | $207.7M | -56.4% |
| FY2022 | $476.0M | -20.1% |
| FY2021 | $595.8M | +144.3% |
| FY2020 | $243.9M | -24.5% |
| FY2019 | $323.1M | +79.9% |
| FY2018 | $179.6M | +101.0% |
| FY2017 | $89.4M | +40.4% |
| FY2016 | $63.6M | -50.3% |
| FY2015 | $127.9M | +200.1% |
As of FY2024 · SEC Form 10-K · Last checked Jul 3, 2026